DETERMINATION OF MEDROXYPROGESTERONE ACETATE IN SERUM BY HPLC WITH PEROXYOXALATE CHEMILUMINESCENCE DETECTION USING A FLUOROGENIC REAGENT, 4-(N,N-DIMETHYLAMINOSULPHONYL)-7-HYDRAZINO-2,1,3-BENZOXADIAZOLE

被引:19
作者
UZU, S
IMAI, K
NAKASHIMA, K
AKIYAMA, S
机构
[1] UNIV TOKYO,BRANCH HOSP PHARM,3-28-6 MEJIRODAI,BUNKYO KU,TOKYO 112,JAPAN
[2] NAGASAKI UNIV,SCH PHARMACEUT SCI,NAGASAKI 852,JAPAN
关键词
MEDROXYPROGESTERONE ACETATE; PEROXYOXALATE CHEMILUMINESCENCE DETECTION; REVERSED-PHASE HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; 4-(N; N-DIMETHYLAMINOSULPHONYL)-7-HYDRAZINO-2; 1,3-BENZOXADIAZOLE; HYDRAZONE; HUMAN SERUM;
D O I
10.1016/0731-7085(91)80107-K
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The high-performance liquid chromatographic determination of medroxyprogesterone acetate (MPA with peroxyoxalate chemiluminescence (PO-CL) detection is described. The spiked serum containing MPA was extracted on Bond-Elut C18 columns and derivatized with 4-(N,N-dimethylaminosulphonyl)-7-hydrazino-2,1,3-benzoxadiazole (DBD-H). The hydrazone of MPA with DBD-H was confirmed to be a mono-DBD-derivative. The reaction mixture was separated by direct injection onto a C18 analytical column, and quantified by PO-CL detection. The linear range of the standard curve, in serum, was 15.6-96.6 ng ml-1 with a detection limit of 9 ng ml-1 using only 100 mul of serum, while the detection limit of standard MPA derivatized with DBD-H was 8.7 fmol per injection. The relative standard deviation of the method was 7.4% at 19.3 ng and 1.7% at 77.3 ng ml-1.
引用
收藏
页码:979 / 984
页数:6
相关论文
共 14 条
[1]   EFFECT OF TETRAHYDROFURAN ON REVERSED-PHASE LIQUID-CHROMATOGRAPHIC SEPARATION OF DANSYL-HYDRAZONES OF OXO-STEROIDS [J].
IMAI, K ;
HIGASHIDATE, S ;
TSUKAMOTO, Y ;
UZU, S ;
KANDA, S .
ANALYTICA CHIMICA ACTA, 1989, 225 (02) :421-424
[2]   SENSITIVE DETECTION OF OXO-STEROIDS AND OXO-BILE ACIDS BY LIQUID-CHROMATOGRAPHY WITH PEROXYOXALATE CHEMI-LUMINESCENCE DETECTION [J].
IMAI, K ;
HIGASHIDATE, S ;
NISHITANI, A ;
TSUKAMOTO, Y ;
ISHIBASHI, M ;
SHODA, J ;
OSUGA, T .
ANALYTICA CHIMICA ACTA, 1989, 227 (01) :21-27
[3]   SPECIFIC AND SENSITIVE QUANTITATION OF MEDROXYPROGESTERONE ACETATE IN HUMAN-SERUM BY GAS-CHROMATOGRAPHY MASS-SPECTROMETRY [J].
JARVINEN, T ;
KEINONEN, T ;
AURIOLA, S ;
PEURA, P ;
HIRVONEN, E ;
PALVA, E .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1989, 495 :13-20
[4]  
JOHANSSON EDB, 1986, ACTA PHARMACOL TOX, V58, P311
[5]   COMPARISON OF MASS-SPECTROMETRY AND RADIOIMMUNOASSAY TO MEASURE MEDROXYPROGESTERONE ACETATE IN PATIENTS WITH ENDOMETRIAL CANCER [J].
KARKKAINEN, J ;
VESTERINEN, E ;
STENMAN, UH ;
ADLERCREUTZ, H ;
NIEMINEN, U ;
WIDHOLM, O .
EUROPEAN JOURNAL OF CANCER, 1990, 26 (09) :975-977
[6]  
PANNUTI F, 1982, CANCER TREAT REP, V66, P2043
[7]  
Pannuti F, 1976, Panminerva Med, V18, P129
[8]   SIMPLE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR THE DETERMINATION OF MEDROXYPROGESTERONE ACETATE IN HUMAN-PLASMA [J].
READ, J ;
MOULD, G ;
STEVENSON, D .
JOURNAL OF CHROMATOGRAPHY, 1985, 341 (02) :437-444
[9]   RADIOIMMUNOASSAY FOR SERUM MEDROXYPROGESTERONE ACETATE [J].
SHRIMANKER, K ;
SAXENA, BN ;
FOTHERBY, K .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1978, 9 (04) :359-363
[10]   DETERMINATION OF A NOVEL POTENT IMMUNOSUPPRESSANT (FK-506) IN RAT SERUM AND LYMPH BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH CHEMILUMINESCENCE DETECTION [J].
TAKADA, K ;
OHHASHI, M ;
YOSHIKAWA, H ;
MURANISHI, S ;
NISHIYAMA, M ;
YOSHIDA, H ;
HATA, T ;
TANAKA, H .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1990, 530 (01) :212-218